Business Description
PT Millennium Pharmacon International Tbk
ISIN : ID1000072804
Compare
Compare
Traded in other countries / regions
SDPC.Indonesia IPO Date
1990-05-07Description
PT Millennium Pharmacon International Tbk is engaged in distributing medicines, food supplements, and medical disposables. The operating segments of the group are Prescription medicine, Non-prescription medicine, and Medical devices, of which the majority of the revenue is derived from the Prescription Medicine segment.. The company's geographical segments are Java, Sumatera, Kalimantan, Sulawesi, and Bali.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | 0.17 | |||||
| Debt-to-Equity | 2.78 | |||||
| Debt-to-EBITDA | 6.44 | |||||
| Interest Coverage | 1.62 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 2.68 | |||||
| Beneish M-Score | -1.9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8.4 | |||||
| 3-Year EBITDA Growth Rate | 22.1 | |||||
| 3-Year EPS without NRI Growth Rate | 115.6 | |||||
| 3-Year Book Growth Rate | 6.6 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.72 | |||||
| 9-Day RSI | 33.77 | |||||
| 14-Day RSI | 39.08 | |||||
| 6-1 Month Momentum % | 5.07 | |||||
| 12-1 Month Momentum % | -8.81 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.13 | |||||
| Quick Ratio | 0.73 | |||||
| Cash Ratio | 0.01 | |||||
| Days Inventory | 58.44 | |||||
| Days Sales Outstanding | 73.49 | |||||
| Days Payable | 58.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.87 | |||||
| Dividend Payout Ratio | 0.12 | |||||
| 3-Year Dividend Growth Rate | 26 | |||||
| Forward Dividend Yield % | 1.87 | |||||
| 5-Year Yield-on-Cost % | 1.06 | |||||
| Shareholder Yield % | -66.7 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 8.54 | |||||
| Operating Margin % | 2.74 | |||||
| Net Margin % | 0.7 | |||||
| FCF Margin % | -3.38 | |||||
| ROE % | 9.36 | |||||
| ROA % | 1.55 | |||||
| ROIC % | 6.63 | |||||
| ROC (Joel Greenblatt) % | 11.49 | |||||
| ROCE % | 29.71 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 5.9 | |||||
| PE Ratio without NRI | 5.82 | |||||
| Shiller PE Ratio | 8.94 | |||||
| Price-to-Owner-Earnings | 4.92 | |||||
| PEG Ratio | 0.5 | |||||
| PS Ratio | 0.05 | |||||
| PB Ratio | 0.53 | |||||
| Price-to-Tangible-Book | 0.72 | |||||
| EV-to-EBIT | 9.37 | |||||
| EV-to-EBITDA | 7.73 | |||||
| EV-to-Revenue | 0.26 | |||||
| EV-to-FCF | -7.75 | |||||
| Price-to-DCF (Earnings Based) | 0.55 | |||||
| Price-to-Median-PS-Value | 0.92 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.4 | |||||
| Price-to-Graham-Number | 0.45 | |||||
| Price-to-Net-Current-Asset-Value | 1.63 | |||||
| Earnings Yield (Greenblatt) % | 10.67 | |||||
| FCF Yield % | -75.62 | |||||
| Forward Rate of Return (Yacktman) % | -4.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PT Millennium Pharmacon International Tbk Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil Rp) | 3,847,837.107 | ||
| EPS (TTM) (Rp) | 21.068 | ||
| Beta | -1.44 | ||
| Volatility % | 13.51 | ||
| 14-Day RSI | 39.08 | ||
| 14-Day ATR (Rp) | 10.478862 | ||
| 20-Day SMA (Rp) | 152.35 | ||
| 12-1 Month Momentum % | -8.81 | ||
| 52-Week Range (Rp) | 121 - 183 | ||
| Shares Outstanding (Mil) | 1,274 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PT Millennium Pharmacon International Tbk Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PT Millennium Pharmacon International Tbk Stock Events
| Event | Date | Price(Rp) | ||
|---|---|---|---|---|
| No Event Data | ||||
PT Millennium Pharmacon International Tbk Frequently Asked Questions
What is PT Millennium Pharmacon International Tbk(ISX:SDPC)'s stock price today?
The current price of ISX:SDPC is Rp135.00. The 52 week high of ISX:SDPC is Rp183.00 and 52 week low is Rp121.00.
When is next earnings date of PT Millennium Pharmacon International Tbk(ISX:SDPC)?
The next earnings date of PT Millennium Pharmacon International Tbk(ISX:SDPC) is .
Does PT Millennium Pharmacon International Tbk(ISX:SDPC) pay dividends? If so, how much?
The Dividend Yield %  of PT Millennium Pharmacon International Tbk(ISX:SDPC) is 1.87% (As of Today), Highest Dividend Payout Ratio of PT Millennium Pharmacon International Tbk(ISX:SDPC) was 0.47. The lowest was 0.04. And the median was 0.12. The  Forward Dividend Yield % of PT Millennium Pharmacon International Tbk(ISX:SDPC) is 1.87%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers